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Dear Editor:
A recent study published in the Revista Brasileira de 
Medicina Tropical by Coutinho et al highlighted the impact 
of American visceral leishmaniasis (AVL) on patients living 
with human immunodeficiency virus infection and acquired 
immune deficiency syndrome (HIV/AIDS); they highlighted 
both the high potential for morbidity and mortality and the 
challenges related to therapeutic management in this patient 
group1. However, although there is a growing concern regarding 
diagnosis and treatment of AVL in this specific population, 
the current approaches and recommendations regarding 
prevention of not only AVL but also other zoonotic diseases—
diseases transmitted naturally from animals to humans—in 
immunocompromised patients also deserve attention; physicians 
as well as other health professionals such as veterinarians need 
to pay attention to this issue2.
AVL is a classic example of a zoonotic disease and its 
importance as a major public health challenge with respect 
to control and prevention is well known3. The expansion of 
transmission areas such as large urban settlements adds to this 
issue. In such scenarios, humans are often exposed to potential 
reservoir animals or animal hosts in various situations, including 
workplace, diet, and household. Irrespective of the cause, 
immunocompromised individuals present both a higher risk of 
infection and greater potential for more severe clinical course4,5. 
The profile of patients living with HIV/AIDS and illness (AVL) 
studied by Coutinho et al. is just one of the innumerable possible 
immunocompromised-zoonosis binomials1. The number of 
immunocompromised patients is increasing due to factors 
such as increase in number of transplants and therapeutic 
approaches with biological and chemotherapeutic agents. In 
addition, more than 200 zoonotic diseases are known to affect 
humans; due to climatic, environmental, and behavioral factors, 
many of these present great potential for (re)emergence and 
endemic establishment. A number of zoonotic diseases that 
affect immunocompromised individuals have been described, 
including campylobacteriosis, salmonellosis, bartonellosis, 
pasteurellosis, leptospirosis, brucellosis, cryptosporidiosis, 
giardiasis, toxoplasmosis, sporotrichosis, histoplasmosis, 
cryptococcosis, and rhodococcosis6,7. Some diseases such 
as cryptococcosis (extrapulmonary form), chronic intestinal 
cryptosporidiosis, salmonellosis (non-typhoid), cerebral 
toxoplasmosis, and Chagas' disease (reactivated form) are also 
included in the Centers for Disease Control and Prevention 
(CDC) criterion that was adapted from the definition of AIDS8.
In this context, except for studies on HIV-Chagas' 
disease and HIV-AVL, robust and updated information on 
the prevalence and impact of other zoonotic diseases among 
immunocompromised individuals is scarce or even absent 
in some endemic countries. The Clinical Protocols and 
Therapeutic Guidelines for Management of HIV Infection 
in Current Adults only recommend primary and secondary 
prophylaxis for some opportunistic infections, including 
toxoplasmosis and cryptococcosis, but do not offer general or 
specific recommendations for prevention of the majority of 
zoonotic infections9. The risk of Cryptosporidium, Bartonella, 
and Sporothrix  infection due to living with pets, consumption 
of fresh milk products in natura and eventual Brucella 
contamination, contact with horses and potential exposure 
to Rhodococcus equi, environments with excreta of bats and 
birds, and presence of Histoplasma and Cryptococcus are just 
a few examples of not infrequent risk situations encountered 
by immunocompromised individuals; little attention is paid to 
this issue in either clinical practice or in recommendations for 
guidelines and protocols7.
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With respect to the effect of zoonotic infections on human 
health, much information is not available for these vulnerable 
individuals; there are few recommendations for care for this group 
of patients. In a scenario where endemic or emerging zoonotic 
diseases remain a challenge to public health and where the number 
of immunocompromised patients is progressively increasing, 
reducing infection risk is one of the main strategies for minimizing 
the morbidity and mortality associated with zoonotic infections10.
The One Health principles should be a guiding element 
in the logic of knowledge-practice-attitude by those involved 
in drawing up recommendations in clinical protocols and 
guidelines. In addition, those responsible for healthcare of 
immunocompromised patients should not restrict themselves 
to only patients living with HIV/AIDS11. An additional strategy 
might be the involvement of veterinary professionals in the 
prevention of zoonotic diseases in the human population with 
respect to different scenarios such as clinical practice for domestic 
and sylvatic pets, consultation in the food production chain, and 
multidisciplinary public health programs. This, in addition to 
the current medical practice recommendations and protocols, 
would help improve the efficacy of prevention of zoonotic 
diseases among (but not only) immunocompromised patients12. 
Thus, it is expected that medical-scientific entities, including 
the Brazilian Society of Tropical Medicine, that are active in the 
dissemination of studies and research, in promotion of technical-
scientific discussions, and especially in elaboration of specific 
clinical protocols and guidelines, will consider the subject of 
multidisciplinary approaches for prevention of zoonosis among 
the immunocompromised population in different scenarios.
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